Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SARS and Avian Flu -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (1132)	1/2/2004 10:33:14 PM
From: Biomaven	Read Replies (5) \| Respond to of 4232

This "low titer" news likely rules out one speculation of mine - that this patient was originally infected with "standard" SARS and then over several months the virus mutated enough in this patient to re-emerge symptomatically (with the original virus being cleared). However if that had been the case then he would presumably still have a reasonably high titer to "standard" SARS. It may turn out that the virus mutates enough over time that we'll never know what to expect each new "season." But at least the Chinese don't seem to be covering things up this year. Too bad they haven't been more proactive on stopping the civet (and the like) trade though. Peter